NeonMind Manufactures 4 Superfood Mushroom Coffees

- October 27th, 2020

Better Plant Sciences Inc. or is pleased to announce that its majority owned subsidiary NeonMind Biosciences has completed an initial production run of all four of its Ayurvedic, functional mushroom coffees.Figure 1: NeonMind Manufactures 4 Superfood Mushroom CoffeesTo view an enhanced version of Figure 1 please visit: this production run successfully completed, we are now prepared to begin consumer testing. We are …

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce that its majority owned subsidiary NeonMind Biosciences (“NeonMind”) has completed an initial production run of all four of its Ayurvedic, functional mushroom coffees.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/66901_b3bb261db486a838_001.jpg

Figure 1: NeonMind Manufactures 4 Superfood Mushroom Coffees

To view an enhanced version of Figure 1 please visit:
https://orders.newsfilecorp.com/files/6377/66901_b3bb261db486a838_001full.jpg

“With this production run successfully completed, we are now prepared to begin consumer testing. We are also lining up distribution and are preparing to begin tests for digital marketing for the website prior to its launch,” said Penny White, CEO of Better Plant. “We are excited to be able to fulfill the growing consumer appetite for functional food products that promote good health.”

Functional foods are food that are demonstrated to have physiological benefits and/or reduce the risk of chronic disease beyond just providing nutrition alone.

This production run includes four unique SKUs, which are all infused with Ayurveda botanicals:

Two instant superfood mushroom coffee blends for on-the go:

  • Rest Blend: Contains Lion’s Mane, Reishi, Ashwagandha and Turmeric
  • Energize Blend: Contains Turkey Tail, Cordyceps, Holy Basil and Moringa

Two traditional roasted superfood mushroom coffee blends:

  • Focus Blend (Dark Roast): Contains Lion’s Mane, Reishi, Gotu Kola, Brahmi
  • Protect Blend (Medium Roast): Turkey Tail, Cordyceps, Moringa and Amla

“When selecting partners such as a co-packer for functional food production, it is crucial to find alignment on safety, nutrition, quality and values,” said Bhavna Solecki, Director of Research and Product Development for Better Plant. “Production facilities should have suitable techniques, methods, and tools, to keep and enrich the nutritive values and bioactivity of the products, as well as be able to propose future directions for food analytical methodologies to refine the process of sorting, grinding, conveying, processing and packaging systems. They must also be able to provide nutritional facts and quality of food and contents of nutrients and bio active components using third party analysis.”

Each batch also goes through third party microbial testing with a certificate of analysis issued by the facility to enhance the homogeneity and stability of the final product for storage and shelf life.

Grand View Research reported in 2019 that the functional foods market is expected to reach USD $275.77 billion by 2025.

About NeonMind Biosciences Inc.
NeonMind is engaged in research and development of products that use medicinal and psychedelic mushrooms to optimize human health and performance. The company is launching a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion’s mane and turkey tail mushrooms. NeonMind is also engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and plans to soon begin preclinical trials to study its pending psychedelic medicine patents. NeonMind owns 18% of Translational Life Sciences Inc. Better Plant Sciences owns approximately 50% of the issued and outstanding stock of NeonMind.

About Better Plant Sciences Inc.
Better Plant develops and acquires intellectual property and other assets related to plant-based products and therapeutics. Through its integrated business model, Better Plant develops, manufactures, markets, sells and distributes plant-based products. It owns over 400 proprietary product formulas. It operates websites and sells through eCommerce, Amazon and through a retail store network over 150 plant based products for body, baby and home under the brands JUSU, Urban Juve and Wright & Well. Its 50% majority-owned subsidiary NeonMind Biosciences Inc. is launching a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion’s mane and turkey tail mushrooms. NeonMind is also engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and has applied for Health Canada approval to begin preclinical trials to study its pending psychedelic medicine patents.

For more information about Better Plant, visit www.betterplantsciences.com or follow @betterplantsciences on Instagram.

Investor Relations Contact:

Penny White, President & CEO

Ali Dumanski, Investor Relations

invest@betterplantsciences.com

1-833-514-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of COVID-19, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Better cautions readers not to place undue reliance on forward-looking statements provided by Better, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66901

News Provided by Newsfile via QuoteMedia

Find out what experts are saying about the future of cannabis

 
Read our 2019 conference report today
 

Leave a Reply